A biotech company developing innovative microneedle-based therapeutics
array-patch.comCork, IrelandBiotech
4 sources · checked 1 time, last 2h ago
The announced second close adds €1.6 million; €3.2 million is the cumulative seed financing total, not the new-money amount.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed ext. | $1.8M €3.2M financing total €1.6 million | 2026-11-05 | not stated | 2 outlets. #68 in Trending |
4 sources · checked 1 time, last 2h ago [ VERIFIED · CORRECTED ] read against 3 of 4 sources
The announced second close adds €1.6 million; €3.2 million is the cumulative seed financing total, not the new-money amount. | ||||
ArrayPatch develops pain-free, dissolving microneedle patches that deliver medicines through the skin for healthcare professionals and their patients.
ArrayPatch is addressing the patient and environmental problems associated with traditional injections with a polymer-free microneedle patch whose needles are made entirely from the medicine, enabling higher drug loading and painless delivery. Its completed €3.2 million seed financing is intended to accelerate first-in-human development of GLP-DerMap for obesity and diabetes and VIS-DerMap for basal cell carcinoma, while the company continues work on nail-fungus treatment.
Checked against 8 sources today
Also named as backers in company research: Dr. Mark Ledwidge, EAF, InterTradeIreland Seedcorn Investor Readiness Competition, IDEATE Ireland, SPRINT accelerator programme